New Study From JAMA Links Rybelsus Usage to NAION A new JAMA study published on July 3, 2024, links the use of semaglutide such as Rybelsus to an increased risk of serious eye conditions such as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Similarly, symptoms of gallbladder disease (right upper quadrant pain, fever, jaundice) should prompt urgent assessment, as cholelithiasis risk increases with rapid weight loss
Your natural GHK-Cu levels decline significantly with age
If you're exploring whether Mounjaro is right for you or waiting for future treatments like Retatrutide once approved, our team is here to provide clear, medically guided support every step of the way.
Journal reference: Tatum KL, Dahman B, Stevenson A, et al
WADA prohibited in competitive sport